Live from the NIH registry
Studies recruiting near Athens right now
Top 25 of 70 recruiting studies, sorted by proximity — each links to its official registry page
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
University Cancer & Blood Center, LLC — Athens, Georgia (0.9 mi)
· Sponsor: Eli Lilly and Company
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
University Cancer and Blood Center LLC — Athens, Georgia (0.9 mi)
· Sponsor: NRG Oncology
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma
Phase 2, Phase 3
Interventional 982 participants sought
University Cancer & Blood Center, LLC — Athens, Georgia (0.9 mi)
· Sponsor: Pfizer
Mechanisms of Uterine Fluid Absorption During Early Pregnancy ( ELF Study)
Endometriosis, Endometrioma
N/A
Observational 140 participants sought
University of Georgia — Athens, Georgia (0.9 mi)
· Sponsor: Johns Hopkins University
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
University Cancer and Blood Center LLC — Athens, Georgia (0.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Carcinoma, Non-Small-Cell Lung
Phase 2
Interventional 480 participants sought
University Cancer And Blood Center LLC — Athens, Georgia (0.9 mi)
· Sponsor: Janssen Research & Development, LLC
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 626 participants sought
University Cancer & Blood Center (UCBC) - Athens — Athens, Georgia (0.9 mi)
· Sponsor: Mirati Therapeutics Inc.
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Athens, Georgia (0.9 mi)
· Sponsor: Hoffmann-La Roche
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Prostate Cancer
Phase 2, Phase 3
Interventional 443 participants sought
University Cancer and Blood Center LLC — Athens, Georgia (0.9 mi)
· Sponsor: Novartis Pharmaceuticals
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Intestinal Neoplasms, Gastrointestinal Neoplasms
Phase 3
Interventional 800 participants sought
University Cancer & Blood Center, LLC — Athens, Georgia (0.9 mi)
· Sponsor: Pfizer
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
Non-small Cell Lung Cancer
Phase 2
Interventional 66 participants sought
University Cancer & Blood Center (UCBC) - Athens — Athens, Georgia (0.9 mi)
· Sponsor: Teligene US
A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation
Atrial Fibrillation (AF), Persistant Atrial Fibrillation
N/A
Interventional 699 participants sought
Piedmont Athens Regional — Athens, Georgia (0.9 mi)
· Sponsor: Boston Scientific Corporation
Changes in 24-hour Activity Cycle Behaviors During a Time-Restricted Eating Intervention in College-Aged Women
Sleep Quality, Compliance
N/A
Interventional 36 participants sought
Physical Activity Measurement Lab — Athens, Georgia (0.9 mi)
· Sponsor: University of Georgia
Multi-level Predictors of Structural Racism and Discrimination and Associations With Health and Well-being Across the Life Course in Diverse Families
Racially/Ethnically Diverse Families From Urban Settings
N/A
Observational 631 participants sought
University of Georgia — Athens, Georgia (0.9 mi)
· Sponsor: University of Colorado, Denver
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Metastatic Non-small Cell Lung Cancer
Phase 3
Interventional 744 participants sought
Research Site — Athens, Georgia (0.9 mi)
· Sponsor: AstraZeneca
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung
Phase 3
Interventional 700 participants sought
University Cancer & Blood Center, LLC — Athens, Georgia (0.9 mi)
· Sponsor: Eli Lilly and Company
Steps Towards Osteoarthritis Prevention
Anterior Cruciate Ligament Injuries
N/A
Interventional 56 participants sought
University of Georgia — Athens, Georgia (0.9 mi)
· Sponsor: University of Georgia
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Triple Negative Breast Neoplasms
Phase 3
Interventional 1,000 participants sought
University Cancer & Blood Center, LLC ( Site 0023) — Athens, Georgia (0.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Non Small Cell Lung Cancer, Triple Negative Breast Cancer
Phase 1
Interventional 85 participants sought
University Cancer & Blood Center — Athens, Georgia (0.9 mi)
· Sponsor: Compass Therapeutics
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Colorectal Neoplasms
Phase 3
Interventional 700 participants sought
University Cancer And Blood Center LLC — Athens, Georgia (0.9 mi)
· Sponsor: Janssen Research & Development, LLC
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Pulmonary Hypertension Associated With HFpEF
Phase 3
Interventional 540 participants sought
Tenax Investigational Site — Athens, Georgia (0.9 mi)
· Sponsor: Tenax Therapeutics, Inc.
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
Locally Advanced Breast Cancer, Unresectable Breast Carcinoma
Phase 1, Phase 2
Interventional 380 participants sought
University Cancer & Blood Center, LLC — Athens, Georgia (0.9 mi)
· Sponsor: BioNTech SE
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
Advanced Breast Cancer, Early Breast Cancer
Phase 1
Interventional 176 participants sought
University Cancer & Blood Center, LLC — Athens, Georgia (0.9 mi)
· Sponsor: TerSera Therapeutics LLC
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
HER2-positive Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Phase 3
Interventional 840 participants sought
Research Site — Athens, Georgia (0.9 mi)
· Sponsor: AstraZeneca
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2
Interventional 81 participants sought
University Cancer and Blood Center LLC — Athens, Georgia (0.9 mi)
· Sponsor: National Cancer Institute (NCI)